OR31-06 Gender-Affirming Hormone Therapy Affects Serum Cystatin C-based eGFR In Transgender Individuals

Disclosure: S.A. van Eeghen: None. C. Wiepjes: None. N. Nokoff: None. P. Bjornstad: None. M. Den Heijer: None. D. van Raalte: None. Background: Previous studies in transgender individuals have shown that masculinizing (testosterone) hormone therapy increases and feminizing (estradiol combined with a...

Descripción completa

Detalles Bibliográficos
Autores principales: van Eeghen, Sarah A, Wiepjes, Chantal, Nokoff, Natalie, Bjornstad, Petter, Heijer, Martin Den, van Raalte, Daniël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Transgender Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555006/
http://dx.doi.org/10.1210/jendso/bvad114.2102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555006/
http://dx.doi.org/10.1210/jendso/bvad114.2102

Ejemplares similares